Li Jiayi, Ge Jianrong, Ran Na, Zheng Changwu, Fang Yumeng, Fang Danna, Yang Qian, Ma Yeling
School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, China.
NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
J Inflamm (Lond). 2023 Jul 24;20(1):25. doi: 10.1186/s12950-023-00351-0.
Infectious preterm birth (PTB) is one of the most important causes of perinatal death. It is difficult to find reliable biomarkers accurate to gestational weeks for infectious PTB prediction clinically. Infectious PTB is found usually accompanied with immune imbalance. Thus, the systematic study to find the priority of inflammatory biomarkers and innovative inflammatory clusters for infectious PTB prediction is urgently needed.This systematic study that focused on the inflammatory clusters and infectious PTB in the PubMed database was analyzed by using the criteria of the Population, Intervention, Comparison, Outcome, and Study design (PICOS) framework according to the recommendations of preferred reporting items for systematic reviews and meta-analysis (PRISMA).The network meta-analyzed results showed that the prioritization of the inflammatory factors for infectious PTB prediction is soluble tumor necrosis factor receptor 2 (sTNFR2) > tumor necrosis factor α (TNFα) > interleukin-10 (IL-10) > interleukin-6 (IL-6) > C-reactive protein (CRP) > interleukin-1β (IL-1β). Furthermore, the results also indicated that global consideration of multiple inflammatory factors, such as CRP/IL-1β/IL-6 biomarker cluster in gestational 27-34 weeks, and the tumor necrosis factor/nerve growth factor (TNF/NGF) family during gestational 25-33 weeks, were potential biomarker clusters that specific for infectious PTB prediction.This study systematically pointed out prioritization of the inflammatory factors for infectious PTB prediction. The results also provided evidence that maternal inflammatory clusters can predict infectious PTB occurrence at accurate gestational week. The global consideration of multiple inflammatory factors at accurate gestational age is highlighted.
感染性早产是围产期死亡的最重要原因之一。临床上很难找到准确到孕周的可靠生物标志物来预测感染性早产。感染性早产通常伴有免疫失衡。因此,迫切需要进行系统研究以找出用于预测感染性早产的炎症生物标志物及创新性炎症簇的优先级。根据系统评价和荟萃分析的首选报告项目(PRISMA)的建议,使用人群、干预措施、对照、结局和研究设计(PICOS)框架标准,对PubMed数据库中聚焦于炎症簇和感染性早产的这项系统研究进行了分析。网络荟萃分析结果显示,用于预测感染性早产的炎症因子优先级为可溶性肿瘤坏死因子受体2(sTNFR2)>肿瘤坏死因子α(TNFα)>白细胞介素-10(IL-10)>白细胞介素-6(IL-6)>C反应蛋白(CRP)>白细胞介素-1β(IL-1β)。此外,结果还表明,综合考虑多种炎症因子,如孕27 - 34周时的CRP/IL-1β/IL-6生物标志物簇,以及孕25 - 33周时的肿瘤坏死因子/神经生长因子(TNF/NGF)家族,是预测感染性早产的潜在特异性生物标志物簇。本研究系统地指出了用于预测感染性早产的炎症因子优先级。结果还提供了证据表明母体炎症簇可在准确孕周预测感染性早产的发生。强调了在准确孕周综合考虑多种炎症因子。